MANUFACTURING RISK ASSESSMENT STUDY FOR STERILE DRY POWDER INJECTION OF CEFTRIAXONE SODIUM
|
|
- Warren Flynn
- 5 years ago
- Views:
Transcription
1 WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES Patel et al. SJIF Impact Factor Volume 5, Issue 6, Research Article ISSN MANUFACTURING RISK ASSESSMENT STUDY FOR STERILE DRY POWDER INJECTION OF CEFTRIAXONE SODIUM Divyanginee Patel 1 *, Rakesh Kaul 2 and Ankita Bhavsar 1 1 Sat Kaival College of Pharmacy, Sarsa crossroads, Sarsa Ta. Dist. Anand, Gujarat, India. 2 Pharmanza (India) Pvt. Ltd. 70/1, G.I.D.C. Estate, Kansari , Khambhat, Gujarat, India. Article Received on 12 Apri l2016, Revised on 03 May 2016, Accepted on 24 May 2016 DOI: /wjpps *Corresponding Author Divyanginee Patel Sat Kaival College of Pharmacy, Sarsa crossroads, Sarsa Ta. Dist. Anand, Gujarat, India. ABSTRACT The objective of this study was to assess and mitigate the risk at all stages before the manufacturing process of Ceftriaxone sodium (CFTX) dry powder injection was initiated. To evaluate the current controls and decide the future actions to be taken for the improvement of product/process reliability and quality of the product for commercial use of early identification and elimination of potential product/process failure modes. The method used was Failure Mode Effect Analysis (FMEA). It is a systematic, proactive method for evaluating a process to identify where and how it might fail and to assess the relative impact of different failures, in order to identify the parts of the process that are most in need of change. Subjected a sterile dry powder injection to a failure mode effect analysis, including technical risks as well as risks related to human failure, which break down the formulation into the process steps and identified possible failure modes for each step, each failure mode was ranked on the estimated frequency of occurrence, detectability and severity. Failure risks were calculated by Risk Priority Number (RPN). Results were predicted by a risk priority number that the risk is acceptable, unacceptable or intolerable. According to the results, corrective actions are taken.this article describes practical ways to analyze the risks to the quality system, providing the way to achieving effective and efficient quality management and compliance. Risk management improves decision making if a quality problem arises. KEYWORDS: FMEA, dry powder injection, risk assessment, RPN. Vol 5, Issue 6,
2 INTRODUCTION To ensure the quality is built into pharmaceutical products, the most up to date technologies and concepts of and concepts of risk management should be incorporated into the manufacturing process. As part of this new approach, work was done to evaluate the filling process of CFTX dry powder injection in order to reduce its associated risks. Risk is understood as the combination of the probability of occurrence of harm and the severity of that harm. [1] CFTX is the semi synthetic 3rd generation cephalosporin drug of antibiotic/anti bacterial class. During manufacturing, especially in filling of the powder, the powder may exposed to an environment which may cause allergic reactions and potential health effects. It is carcinologic also. Conditions like humidity, warming and light should be avoided due to instability. [2] The manufacturing of sterile medicinal products is subjected to special requirements in order to minimize risks of microbiological contamination and particulate or pyrogen contamination. That depends on the skill, training and attitudes of the personnel involved. Quality assurance is particularly important, and this type of manufacture must strictly follow carefully established and validated methods for preparation. [3] Sterility of CFTX dry powder injection produced by aseptic processing should obtained guarentting the conformity of processes different factors. To obtain sterile products, it is essential that all processing should be done in a way that minimizes the risk of contamination hazard. [4] A facility for the filling of a sterile dry powder antibiotic comprises the tunnel concept for washing and sterilization of the product containers, a filling unit under laminar airflow with localized vacuum exhaust, a changing room suite, autoclave, airlock, and conventional clean room containing the filling equipment. The need is to reduce the possibility of sensitization and other allergic reactions. Particulate contamination represented as a function of starting materials, container, and closure contribution was assessed. [5] Due to the aforementioned difficulties related to the manufacturing process of CFTX dry powder and the high risk of producing a poor quality product, a risk based analysis was performed to improve the understanding of the filling process and reduce its associated risks before manufacturing. Vol 5, Issue 6,
3 Risk assessment Risk assessment of CFTX dry powder consists of the identification of hazards and the analysis and evaluation of risks associated with exposure to those hazards. Quality risk assessments begin with a well-defined problem description or risk question. As an aid to clearly defining the risks for risk assessment purposes, three fundamental questions are often helpful. 1. What might go wrong? 2. What is the likelihood (probability) it will go wrong? 3. What are the consequences (severity)? Risk identification is a systematic use of information to identify hazards referring to the risk question or problem description. Information can include historical data, theoretical analysis, informed opinions, and the concerns of stakeholders. Risk identification addresses the What might go wrong? question, including identifying the possible consequences. This provides the basis for further steps in the quality risk management process. Risk analysis is the estimation of the risk associated with the identified hazards. It is the qualitative or quantitative process of linking the likelihood of occurrence and severity of harms. In some risk management tools, the ability to detect the harm (detectability) also factors in the estimation of risk. Risk evaluation compares the identified and analyzed risk against given risk criteria. Risk evaluations consider the strength of evidence for all three of the fundamental questions. Severity It is the impact on patient safety, product quality and data integrity. Occurrence It is the likelihood of the fault occurring. Detectability The ability to determine the existence, presence, or fact of a hazard. [1,6] FMEA was developed to assess risk of failure and harm in processes and to identify the most important areas for process improvements. The main objective was the prevention of Vol 5, Issue 6,
4 problems and errors by reducing the RPN. FMEA is a systematic, proactive method for evaluating a process to identify where and how it might fail and to assess the relative impact of different failures, in order to identify the parts of the process that are most in need of change. [7] MATERIALS AND METHODS Material (Ceftriaxone sodium) and equipments used for this study were obtained from Pharmanza (Ind.) Pvt. Ltd., Khambhat, Gujarat, India. Table 1: Equipments used in various unit operations Method Process Equipment name Capacity Vial washing Automatic high speed linear vial 120 vials /min for washing machine 10 ml to 50 ml vials Depyrogination Sterilizing & depyrogenating tunnel - Automatic injectable powder Filling, stoppering and filling with rubber stoppering sealing machine 120 vials /min Metal detection Metal detector - Sterilization (Dry) Dry heat sterilizer - Sterilization (Moist) Rectangular double door horizontal HPHV steam sterilizer - (autoclave) Dehumidification Dehumidifier 1200 cfm The steps someone has to go through to design an FMEA form are described below: 1. Selection of the process The importance of the process in terms of the impact of potential failures was taken into account as selection criteria. Evaluation using FMEA works best on processes that do not have too many sub processes. 2. Review of the process The process was analyzed and described in a flow chart and the process design was studied thoroughly for the efficient output. 3. Brainstorm potential failure modes Each stage of the process was studied and identifies the ways it could potentially fail or the things that might go wrong. Vol 5, Issue 6,
5 4. List of potential effects of each failure mode List of the potential effects and their probable failure were prepared. Cause and effects analysis (Fishbone diagram) was used for this step. [4] 5. Assign a severity rating for each effect Each effect was given its own severity rating (from 1 to 10, with 10 being the most severe). 6. Assign an occurrence rating for each failure mode After collecting data on the factors responsible for the failure of the product, the failure frequency was determined and they were rated appropriately (from 1 to 10, with 10 being the most likely). 7. Assign a detection rating for each failure mode and effect List of all controls currently in place to prevent each effect of a failure from occurring was prepared and a detection rating was assigned for each item (from 1 to 10, with 10 being a low likelihood of detection). 8. Calculation of the RPN for each effect RPN was calculated by multiplying the severity rating with that of occurrence rating by the detection rating. 9. Prioritize the failure modes for action Depending upon calculation and analysis carried out, the priority order was decided. 10. Taken action to eliminate or reduce the high risk failure modes: The action to be taken for each high risk failure was determined and a person was assigned to implement the action /change. The FMEA of dry powder injection is described in Table 2. The flow chart for the manufacturing of CFTX dry powder injection is shown below Vol 5, Issue 6,
6 Fig. 1: Flow diagram for the production of sterile dry powder injection Vol 5, Issue 6,
7 Table 2: FMEA of dry powder injection Sr. No Failure Modes (Risk identification) During receipt and transferring of raw material contamination may occur Quality, quantity and timing of water supply during washing of vials Compressed air pressure, blowing time Checking HEPA filter integrity Temperature of air may not obtained in depyrogeniation 6 Depyrogination time Speed of conveyer belt during filling Fluffing of powder in filling area Nitrogen flush rate/pressure in filling 10 Filling area conditions Failure Cause (Risk evaluation) Due to the environment, human interferation or by the vendor Unqualified and unquantified distilled water due to poor maintenance of water Air pressure and timing is not maintained properly Improper HEPA filter efficiency, variations in velocity of air, flow pattern of air or leaking of the filter Insufficient heat distribution and heat penetration Insufficient time due to machine speed fault Failure Effects (Risk analysis) Inappropriate quality of raw material which directly affects the quality of finished dosage form Reduced quality of the sterility of vials Improper treatment of air to vials causing improper sterilization Severity Occurrence Detectability R P N Contaminated product Improper sterilization of vials Loss of sterility Unoptimum speed of conveyer belt Improper filling of vials Improper height of filling needle as per specification Pressure required to fill the vials is out of the range Failure in maintenance of area classification Harmful to working personnel in filling area Filling accuracy is not achieved Loss of sterility Vol 5, Issue 6,
8 11 12 Missing or dispatched stoppers Missing or dispatched seals 13 Any defect in labeling Improper carton packaging Mixing up of two different types of packing material Storage room conditions Improper force of stoppering Improper Seal strength uniformity Improper checking of labels including Names and amount of active ingredients, Storage requirements, Control or lot number, Appropriate auxiliary labeling (including precautions) Untrained packing personnel Improper working of personnel Contamination, leakage and moisture absorption May lead to leakage from the vial Misleading labels and market complains May lead to harm to the container and market complain Wrong product storage and use Storage room temperature, humidity Degradation of product Vol 5, Issue 6,
9 RESULTS The key activities performed during risk analysis include understanding the impact of risk, to rank the significance of risk (by scoring 1 to 10), to calculate the risk score (RPN). After the calculation of risk score, the results of the level or priority of the risk were estimated. If the RPN is between 1 and 120, then it is minimum risk and considered as acceptable risk. If the RPN is higher than 120 and lower than 500, then it is medium risk and considered as unacceptable risk. If the RPN is above 500, then it is higher risk and considered as intolerable. Table 3: Risk level and acceptability criteria Table 4: Result of risk acceptability RPN Risk level Risk priority Minimum Acceptable risk 125>500 Medium Unacceptable High Intolerable Sr. no Failure modes (Risk identification) During receipt and transferring of raw material contamination may occur Quality, quantity and timing of water supply during washing of vials Compressed air pressure, blowing time Checking HEPA filter integrity Temperature of air may not obtained in depyrogeniation Failure effects (Risk analysis) Inappropriate quality of raw material which directly affects the quality of finished dosage form Reduced quality of the sterility of vials Improper treatment of air to vials causing improper sterilization R P N Risk priority 150 Unacceptable 144 Unacceptable 280 Unacceptable Contaminated product 144 Unacceptable Improper sterilization of vials 210 Unacceptable 6 Depyrogination time Loss of sterility 240 Unacceptable Corrective actions Take precautions for handling of raw materials, select approved vendor Daily water testing from storage tank Maintain proper air pressure Maintain proper integrity of HEPA filter by regular testing Check and maintain temperature as required Maintain and check the Depyrogination tunnel periodically Vol 5, Issue 6,
10 7 8 9 Speed of conveyer belt during filling Fluffing of powder in filling area Nitrogen flush rate/pressure Improper filling of vials Harmful to working personnel in filling area Filling accuracy is not achieved 168 Unacceptable 270 Unacceptable 70 Acceptable 10 Filling area conditions Loss of sterility 320 Unacceptable Missing or dispatched stoppers Missing or dispatched seals 13 Any defect in labeling Improper carton packaging Mixing up of two different types of packing material Storage room conditions contamination, leakage and moisture absorption May lead to leakage from the vial Misleading labels and market complains May lead to harm to the container and market complain Wrong product storage and use Degradation of product 135 Unacceptable 135 Unacceptable 135 Unacceptable 245 Unacceptable 120 Acceptable 216 Unacceptable Verify and control the speed of conveyer belt Control the height of the filling needle to the fill volume Measure and control air pressure Measure and control the area classification Check the vials properly that any vial has missing or dispatched stopper Check the vials properly that any vial has missing or dispatched seals Check labels properly and verify all details Check primary and secondary containers properly Design label control procedures based on the potential for mix-ups involving different product labels, including different versions of the same label. Assess the adequacy of arrangements to ensure maintenance of appropriate storage and transport conditions (e.g., temperature, humidity, container design) DISSCUSSION Different risk acceptability was found according to RPN. Corrective actions should be taken to improve risk levels. When the risk is intolerable, then work to eliminate the negative event or introduce detection controls is required as a priority. When the risk is unacceptable, work to reduce the risk or control the risk to an acceptable level is required. When the risk is acceptable, then the risk is acceptable and no risk reduction or detection controls are required. Corrective actions are taken to reduce the risk to an acceptable level. CONCLUSION From the above evaluation of risk assessment based on FMEA, it was concluded that various critical steps that were expected to occur at each stage of the manufacturing process, were Vol 5, Issue 6,
11 adequate to reduce the associated risks at a very early stage. This method helped us to focus the various critical steps that were critical to the product quality and process. Also, it eliminates the need of validation of all parameters of the aseptic manufacturing process and just includes few which are found critically. Results can be used to identify high vulnerability elements and to guide resource development for best benefits. So, by early identification and elimination of potential product/process failure modes we can improve product/process reliability and quality of the product for commercial use. AKNOWLEDGEMENT We are grateful to thank Mr. Rakesh Kaul and Mrs. Trupti Dawavala from Pharmanza (Ind) Pvt. Ltd. (Khambhat) for research fellowships. REFERENCES 1. Q9 Quality Risk Management. ICH, 2005; Medicines and Healthcare products Regulatory Agency, UKPAR Ceftriaxone 250mg, 1g and 2g Powder for Solution for Injection PL 24598/ Guide to good manufacturing practice for medicinal products annexes, Annex 1 Manufacture of sterile medicinal products, 2009; Quinto A, Mmenezes C. Design, Validation and control of sterile manufacturing facilities: A brief overview from the perspective of Risk Management and existing Regulations. Pharm Eng, 2010; 30(2): Gerald Prout. Validation and Routine Operation of a Sterile Dry Powder Filling Facility. J Parenter Sci Technol, 1982; 36(5): Lotlikar MV et al. Quality Risk Management (QRM): A Review. J. Drug Delivery Ther, 2013; 3(2): Institute for healthcare improvement, Failure Mode Effect analysis, 2004; Vol 5, Issue 6,
USP <797> LABELING ESTABLISHING BEYOND-USE DATES AND IN-USE TIMES
USP LABELING ESTABLISHING BEYOND-USE DATES AND IN-USE TIMES Each CSP label must state the date beyond which the preparation cannot be used and must be discarded. A CSP may also be labeled with an
More informationUnderstanding safety life cycles
Understanding safety life cycles IEC/EN 61508 is the basis for the specification, design, and operation of safety instrumented systems (SIS) Fast Forward: IEC/EN 61508 standards need to be implemented
More informationAir Handling Unit (AHU) Air handling unit which serves to condition the air and provide the required air movement within a facility.
IOSR Journal of Mechanical and Civil Engineering (IOSR-JMCE) e-issn: 2278-1684,p-ISSN: 2320-334X, Volume 13, Issue 5 Ver. I (Sep. - Oct. 2016), PP 28-35 www.iosrjournals.org. Heating, Ventilation and Air
More informationFMEA- FA I L U R E M O D E & E F F E C T A N A LY S I S. PRESENTED BY: AJITH FRANCIS
FMEA- FA I L U R E M O D E & E F F E C T A N A LY S I S. PRESENTED BY: AJITH FRANCIS 1 OBJECTIVES What is FMEA? Why is an FMEA important? History of FMEA Benefits of FMEA Limitations of FMEA How to conduct
More informationDetermining Occurrence in FMEA Using Hazard Function
Determining Occurrence in FMEA Using Hazard Function Hazem J. Smadi Abstract FMEA has been used for several years and proved its efficiency for system s risk analysis due to failures. Risk priority number
More informationBATCH MANUFACTURING RECORD FOR PRODUCT X,
Expiry PRODUCT X FILL SIZE x ml Effective Written : Revision number: Reviewed : Approved Q.A.: Expiry CERTIFICATION CERTIFICATE OF QUALITY ASSURANCE THIS IS TO CERTIFY THAT THE BATCH No. OF PRODUCT X (TRADE
More informationDiscussion and guidance on the definition and qualification of porous loads
SUMMARY Porous Loads requiring Sterilisation are often a Critical Control Point for the manufacture of Sterile products. Particularly Aseptically filled products. Regulatory guidance in this area is not
More informationCTG Certification Protocol -- Version 3.0 SUMMARY
Date of Test: Test Report Number: SUMMARY Date of Prior Certification: Certified by: Re-certification Due Date: Unit Description: Make : Model: Serial Number: Location: CERTIFIER INFORMATION Name: Client
More informationA. Evaluation of the written program
A. Evaluation of the written program Begin your audit with an evaluation of the written respiratory protection program. In addition to the operating procedures describing respirator selection and use in
More informationHazard and risk analysis in pharmaceutical products 1
QUALITY ASSURANCE OF PHARMACEUTICALS 5. Hazard and risk analysis in pharmaceutical products 1 Application of hazard analysis and critical control point (HACCP) methodology to pharmaceuticals 1. Introduction
More informationAseptic Techniques. Techniques for Sterile Compounding. Pharmacy Technician Training Systems Passassured, LLC
Aseptic Techniques Techniques for Sterile Compounding Pharmacy Technician Training Systems Passassured, LLC Aseptic Techniques, Tech for Sterile Compounding PassAssured's Pharmacy Technician Training Program
More informationCASE STUDY ON RISK ASSESSMENTS FOR CROSS CONTAMINATION. Stephanie Wilkins, PE EMA Workshop June 2017
CASE STUDY ON RISK ASSESSMENTS FOR CROSS CONTAMINATION Stephanie Wilkins, PE EMA Workshop 20-21 June 2017 Objectives How the process is embedded into the QMS Case study to show: Use of data to assess occurrence
More informationPIQCS HACCP Minimum Certification Standards
PIQCS HACCP Minimum Certification Standards In the EU, requirements for the hygiene of food is laid down in Regulation (EC) 852/2004. This regulation establishes general hygiene procedures for food at
More informationREVISITING THE HAZARD ANALYSIS. John E. Rushing, Ph.D. Professor Emeritus, North Carolina State University Principal, Food Technology Consulting, LLC
REVISITING THE HAZARD ANALYSIS John E. Rushing, Ph.D. Professor Emeritus, North Carolina State University Principal, Food Technology Consulting, LLC Principle #1 of HACCP -- Conduct a Hazard Analysis Which
More informationUsing what we have. Sherman Eagles SoftwareCPR.
Using what we have Sherman Eagles SoftwareCPR seagles@softwarecpr.com 2 A question to think about Is there a difference between a medical device safety case and any non-medical device safety case? Are
More informationReliability Engineering. Module 3. Proactive Techniques - Definitions
Reliability Engineering Module 3 1 Proactive Techniques - Definitions Functional Failure: The inability of an asset to meet a desired standard of performance. Failure Cause: The circumstances during design,
More informationRESPIRATOR PERFORMANCE TERMINOLOGY
RESPIRATOR PERFORMANCE TERMINOLOGY The following terms were developed by the American Industrial Hygiene Association Respiratory Protection Committee to represent respirator performance in various contexts.
More informationAseptic Vial and Syringe Filling Narlin B. Beaty, Ph.D. Adelaide Nye
Aseptic Vial and Syringe Filling Narlin B. Beaty, Ph.D. Adelaide Nye Like the preparation of a fine dinner, aseptic filling of vials and syringes is best performed with the highest quality components,
More informationPhase B: Parameter Level Design
Phase B: Parameter Level Design 1 FMEA A chart describing the ways in which the product may fail, the impact, and what has been done to alleviate any problems. Measure of the inability to achieve overall
More informationHydro Plant Risk Assessment Guide
September 2006 Hydro Plant Risk Assessment Guide Appendix E10: Compressed Air System Condition Assessment E10. 1 GENERAL Compressed air systems are key components at hydroelectric power plants. Compressed
More informationPurpose. Scope. Process flow OPERATING PROCEDURE 07: HAZARD LOG MANAGEMENT
SYDNEY TRAINS SAFETY MANAGEMENT SYSTEM OPERATING PROCEDURE 07: HAZARD LOG MANAGEMENT Purpose Scope Process flow This operating procedure supports SMS-07-SP-3067 Manage Safety Change and establishes the
More informationHow to Define Your Systems and Assets to Support Reliability. How to Define Your Failure Reporting Codes to Support Reliability
BACKFED RELIABILITY How to Define Your Systems and Assets to Support Reliability How to Define Your Failure Reporting Codes to Support Reliability How to Generate Risk Prioritization Numbers (RPN) from
More informationSAFETY DATA SHEET INTERNATIONAL FLAVORS & FRAGRANCES
Print Date 08/20/2015 Page 1 (8) SECTION 1. PRODUCT AND COMPANY IDENTIFICATION name : IFF Code : 00044940 Cust. Material : 00044940 MSDS Number : R00000219533 Use Description : Flavour or Fragrance Ingredient
More informationPERFORMANCE QUALIFICATION AND OCCUPATIONAL EXPOSURE LIMIT (OEL) FOR ISOLATOR
wjpmr, 2017,3(7), 157-162 SJIF Impact Factor: 4.103 WORLD JOURNAL OF PHARMACEUTICAL Ratnesh and Vivek et al. AND MEDICAL RESEARCH www.wjpmr.com Research Article ISSN 2455-3301 WJPMR PERFORMANCE QUALIFICATION
More informationLaboratory Chemical Hygiene Plan
Building and Room Numbers: Laboratory Chemical Hygiene Plan Engineering Research Building 1125, 1128, and 1202 Department: Materials Science and Engineering Principal Investigator, Laboratory Manager or
More informationAseptic Processing Achieving Sterility by Design
Aseptic Processing Achieving Sterility by Design James Agalloco Agalloco & Associates FDA Aseptic Perspective In an aseptic process, the drug product, container, and closure are first subjected to sterilization
More informationRespiratory Protection Self Inspection Checklist
Optional Information Name of School: Date of Inspection: Vocational Program/Course/Room: Signature of Inspector: Respiratory Protection Self Inspection Checklist Guidelines: This checklist covers some
More informationFederal Aviation Administration Safety & Human Factors Analysis of a Wake Vortex Mitigation Display System
Safety & Human Factors Analysis of a Wake Vortex Mitigation Display System Presented to: EUROCONTROL Safety R&D Seminar By: Dino Piccione Date: October 23, 2008 Project Objectives Forge a link between
More informationLIGHTHOUSE. Stopper Pop-Up and the Effects on. Container Closure of Sterile Vials. Application Note 101 LIGHTHOUSE
Stopper Pop-Up and the Effects on Container Closure of Sterile Vials Stopper Pop-Up and the Effects on Container Closure of Sterile Vials Introduction Container closure integrity plays an important role
More informationHalf Facepiece Respirator Assembly 5000 Series, Dual Cartridge, Organic Vapor/P95, Disposable
Half Facepiece Respirator Assembly 5000 Series, Dual Cartridge, Organic Vapor/P95, Disposable User Instructions for 3M Organic Vapor Respirator, P95 Assembly 51P71/52P71/53P71 Important: Keep these User
More informationSTANDARDS FOR COMPRESSED GAS TESTING
STANDARDS FOR COMPRESSED GAS TESTING APPLICATION NOTE HPD-002 (US) Introduction This publication provides excerpts from some of the many guidelines and standards that pertain to compressed gases in cleanrooms.
More informationIncorrect Relief Valve Material Causes Release
Incorrect Relief Valve Material Causes Release Lessons Learned Volume 04 Issue 18 2004 USW Purpose Incorrect Relief Valve Material Causes Release To conduct a small group lessons learned activity to share
More informationEvery things under control High-Integrity Pressure Protection System (HIPPS)
Every things under control www.adico.co info@adico.co Table Of Contents 1. Introduction... 2 2. Standards... 3 3. HIPPS vs Emergency Shut Down... 4 4. Safety Requirement Specification... 4 5. Device Integrity
More informationModule No. # 01 Lecture No. # 6.2 HAZOP (continued)
Health, Safety and Environmental Management in Petroleum and Offshore Engineering Prof. Srinivasan Chandrasekaran Department of Ocean Engineering Indian Institute Of Technology, Madras Module No. # 01
More informationSAFETY DATA SHEET. Version: 1.0
Page 1 of 6 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND THE COMPANY/UNDERTAKING Product Identifier Trade Name: Synonyms: Chemical Family: Not established 50% Dextrose Injection, USP Concentrated Dextrose
More informationThe primary purpose of laboratory fume hoods is to keep toxic or irritating vapors out of the general laboratory working area.
Introduction Welcome to the Biosafety Cabinets and Fume Hoods Training Course (OHS_BIO304). This training is required for anyone that will be conducting work and/or research that requires the use of a
More informationSole reliance for sterility or other quality aspects must not be placed on finished product test.
This chapter provides requirements for aseptic production in the manufacture and quality control of veterinary vaccines in accordance with Chapter 1.1.8 Principles of veterinary vaccine production and
More informationModule No. # 04 Lecture No. # 3.1 Case studies (continued) (Refer Slide Time: 00:10)
Health, Safety and Environmental Management in Petroleum and offshore Engineering Prof. Dr. Srinivasan Chandrasekaran Department of Ocean Engineering Indian Institute of Technology, Madras Module No. #
More information1 5 2 Definition of Isolator Technology Isolator Types and Applications 3 Critical Design Considerations 4 Biodecontamination Conclusion and Summary 2
Isolator Technology for Aseptic Manufacturing May 29, 2015 1 1 5 2 Definition of Isolator Technology Isolator Types and Applications 3 Critical Design Considerations 4 Biodecontamination Conclusion and
More informationAUSTRALIA ARGENTINA CANADA EGYPT NORTH SEA U.S. CENTRAL U.S. GULF. SEMS HAZARD ANALYSIS TRAINING September 29, 2011
AUSTRALIA ARGENTINA CANADA EGYPT NORTH SEA U.S. CENTRAL U.S. GULF SEMS HAZARD ANALYSIS TRAINING September 29, 2011 Purpose The purpose of this meeting is to provide guidelines for determination of hazard
More informationSafe High Pressure Water Washing (HPWW) Requirement
Safe High Pressure Water Washing (HPWW) Requirement Index Page Introduction 3 Flow chart of process steps 4-5 Responsibilities 6 Risk assessment process 7-9 Job safety analyses considerations 10-11 Compliance
More information3M Steri-Vac Sterilizer/Aerator GSX Series. For Life Science Applications. Product. Profile
M Steri-Vac Sterilizer/Aerator GSX Series Product Profile Product Profile M Steri-Vac Sterilizer/Aerator GSX Series ethylene oxide (EO) sterilizer/aerators are designed to be used with M Steri-Gas EO Gas
More informationFailure Modes and Effect Analysis of Electro-Pneumatics System
Failure Modes and Effect Analysis of Electro-Pneumatics System Priya Banerjee B. Tech. Electrical and Electronics Engineering, Amity School Of Engineering and Technology, Amity University, Noida, India
More informationJournal of Applied Fluid Transients, Vol 1-1, April 2014 (3-1)
Modeling and Field Verification Study of Air Slam Conditions on kalanit Pipeline System By Yiftach Brunner & Sathish Kumar ir valves are integral part of long water transmission mains and are essential
More informationField Evaluation of ASTM E in Relation to Control Room Habitability Testing and Boundary Maintenance in Nuclear Power Plants.
Field Evaluation of ASTM E741-00 in Relation to Control Room Habitability Testing and Boundary Maintenance in Nuclear Power Plants. Presented By Clinton B. Summers Eric M. Banks NUCON International, Inc.
More informationPREPARATION AND SELF-ADMINISTRATION INSTRUCTIONS FOR PATIENTS
PREPARATION AND SELF-ADMINISTRATION INSTRUCTIONS FOR PATIENTS Hereditary Angioedema Jenny, a real HAE patient TAKE CONTROL OF YOUR HEREDITARY ANGIOEDEMA (HAE) TREATMENT WITH SELF-ADMINISTRATION Choosing
More informationSAFETY DATA SHEET. In accordance with 29 CFR Section 1. Identification of the substance or the mixture and of the supplier
Page ( 6 (05/0/208 Section. Identification of the substance or the mixture and of the supplier. Product Identifier Product identifier: Other identifiers: None.2 Relevant identified uses of the substance
More informationWhitepaper Technical Opinion: Grade A - Air Supply and Local Protection
Whitepaper Technical Opinion: Grade A - Air Supply and Local Protection I N D U S T R Y I N S I G H T S Norman A. Goldschmidt Sr. Principal, President www.geieng.com I N D U S T R Y I N S I G H T S Genesis
More informationM-06 Nitrogen Generator (Nitrogen Making Machine)
Guideline No.M-06 (201510) M-06 Nitrogen Generator (Nitrogen Making Machine) Issued date: 20 th October, 2015 China Classification Society Foreword This Guideline is a part of CCS Rules, which contains
More informationToolkit for safe Use of Microbiological Safety Cabinets(MSC s)
Toolkit for safe Use of Microbiological Safety Cabinets(MSC s) What Do I Need To Do? How Do I Manage the Use of MSC s Recommendations 1 What Do I Need To Do Head of Department? Information, induction,
More informationProficiency Module Syllabus. P601 - Thorough Examination and Testing of Local Exhaust Ventilation Systems
Proficiency Module Syllabus P601 - Thorough Examination and Testing of Local Exhaust Ventilation Systems Aim To provide the methodology, theoretical and practical knowledge to enable candidates to: Understand
More information5.1 Introduction. Learning Objectives
Learning Objectives 5.1 Introduction Statistical Process Control (SPC): SPC is a powerful collection of problem-solving tools useful in achieving process stability and improving capability through the
More informationGerard Sheridan Inspector
Manufacture of Sterile Medicinal Products Areas of Focus for GMP Inspections GMP Information Day; 23rd October 2008. Gerard Sheridan Inspector Date : 23/10/2008 Slide 1 Objectives Highlight areas frequently
More informationFUNDAMENTAL SAFETY OVERVIEW VOLUME 2: DESIGN AND SAFETY CHAPTER I: AUXILIARY SYSTEMS. A high-capacity EBA system [CSVS] [main purge]
PAGE : 1 / 9 5. CONTAINMENT PURGE (EBA [CSVS]) The Reactor Building purge system comprises the following: A high-capacity EBA system [CSVS] [main purge] A low-capacity EBA system [CSVS] [mini-purge] 5.1.
More informationMarine Risk Assessment
Marine Risk Assessment Waraporn Srimoon (B.Sc., M.Sc.).) 10 December 2007 What is Risk assessment? Risk assessment is a review as to acceptability of risk based on comparison with risk standards or criteria,
More informationAssembly and Installation Procedures
Assembly and Installation Procedures for Pall Supracap 100 Capsules 1. Introduction The following procedures must be followed for the installation of Pall Supracap 100 Capsules. The instructions contained
More informationApplication of FMCA as a Tool for Risk Assessment
Application of FMCA as a Tool for Risk Assessment Carl A. Anderson; Robert P. Cogdill; and James K. Drennen, III IFPAC 0 January 007 Baltimore, MD Outline Introduction PAT Process Role of risk assessment
More informationAnnex 6 Good manufacturing practices for sterile pharmaceutical products
World Health Organization WHO Technical Report Series, No. 902, 2002 Annex 6 Good manufacturing practices for sterile pharmaceutical products Introductory note 76 1. General considerations 76 2. Quality
More information1309 Hazard Assessment Fundamentals
1309 Hazard Assessment Fundamentals Jim Marko Manager, Aircraft Integration & Safety Assessment 14 November 2018 Presentation Overview Fail-safe design concept Safety Assessment principles for hazard classification
More informationDilution Sequence Protocol
Dilution Sequence Protocol US Package Insert Multi-Patient (2-5 patients; requires 2 vials of Provocholine) 0.025 0.25 2.5 10 25 Provocholine 100 mg/vial (US NDC 64281-100-06) 1 Provocholine (methacholine
More informationHalf Facepiece Respirator Assembly 5000 Series, Dual Cartridge, Disposable
Half Facepiece Respirator Assembly 5000 Series, Dual Cartridge, Disposable User Instructions for 3M Organic Vapor Respirator Assembly 5101/5201/5301; 3M Organic Vapor/Acid Gas Respirator Assembly 5103/5203/5303;
More informationENS-200 Energy saving trainer
ENS-200 Energy saving trainer Find out about the essential aspects of energy efficiency in compressed air installations Save money Put it into practice Take care of the environment Get training www.smctraining.com
More informationSAFETY DATA SHEET. In accordance with 29 CFR Section 1. Identification of the substance or the mixture and of the supplier
Page ( 7 Issue date: 02/02/207 (02/02/207 In accordance with 29 CFR 90.200 Section. Identification of the substance or the mixture and of the supplier. Product Identifier Product identifier: Other identifiers:
More informationUSING HAZOP TO IDENTIFY AND MINIMISE HUMAN ERRORS IN OPERATING PROCESS PLANT
USING HAZOP TO IDENTIFY AND MINIMISE HUMAN ERRORS IN OPERATING PROCESS PLANT Chris Lyth, Tracerco, Billingham, Cleveland, UK Ian Bradby, ABB Engineering Services, Billingham Cleveland, UK This joint paper
More informationDon t Forget About Fit What You Need to Know About Respirator Fit-testing
Session No. 667 Don t Forget About Fit What You Need to Know About Respirator Fit-testing Scott Larson, BS, MS, CSP, CIH 3M Personal Safety Division St. Paul, MN Megan Torgrude, BS, MPH, CIH 3M Personal
More informationMixing Methacholine Dilutions for Bronchoprovocation Challenge Testing
powder for solution, for inhalation Mixing Methacholine Dilutions for Bronchoprovocation Challenge Testing Provocholine is a registered trademark of Methapharm Inc. Copyright Methapharm Inc. 2016. All
More informationNotes on Risk Analysis
Notes on Risk Analysis MAXIMIZING THE CHANCES OF SUCCESS AERO 401 D. B. KANIPE MARCH, 2016 Focus of Design process Design of Spacecraft Getting the design to work as planned Accomplishing the mission objectives
More informationParallel Session 1A Sterile Manufacture. Denise Coakley. GMP Conference 12 th November 2014
Visual nspection Parallel Session 1A Sterile Manufacture Denise Coakley GMP Conference 12 th November 2014 EU GMP Annex 1: Filled containers of parenteral products should be inspected individually for
More informationPerformance Monitoring Examples Monitor, Analyze, Optimize
Performance Monitoring Examples Monitor, Analyze, Optimize BETA's Performance Assessment service is a low cost remote monitoring service for reciprocating compressors, centrifugal compressors, engines,
More informationCabinet. 1.0 POLICY It is the policy of Calvin College to comply with the MIOSHA Respiratory Protection Standard Part 451.
Calvin College Respiratory Protection Program Prepared by: Date: Heather Chapman 10/7/10 Approved by: Cabinet Revision 2 Date: 1.0 POLICY It is the policy of Calvin College to comply with the MIOSHA Respiratory
More informationSeed Treatment Safety and Regulations Crop Protection Perspective. Chip Witcher / Staff Industrial Hygienist / Syngenta Crop Protection
Seed Treatment Safety and Regulations Crop Protection Perspective Chip Witcher / Staff Industrial Hygienist / Syngenta Crop Protection Objectives The objectives of this presentation are to... - Describe
More informationTECHNICAL INFORMATION SHEET 17. Revision 1 : 2016 MODEL RISK ASSESSMENT FOR THE MANUAL HANDLING OF GAS CYLINDERS
TECHNICAL INFORMATION SHEET 17 Revision 1 : 2016 MODEL RISK ASSESSMENT FOR THE MANUAL HANDLING OF GAS CYLINDERS Copyright 2016 by British Compressed Gases Association. First printed 2009. All rights reserved.
More informationMANUAL DIRECT PURGE OPTION. UNION Instruments GmbH CWD2005 PLUS. General information, safety standards and regulations for direct purge option
MANUAL DIRECT PURGE OPTION UNION Instruments GmbH CWD2005 PLUS General information, safety standards and regulations for direct purge option Version: V1.00 Stand: 24.03.2010 Union Instruments GmbH Zeppelinstr.
More informationAd Hoc GMP Inspections Services Group EC GUIDE TO GOOD MANUFACTURING PRACTICE REVISION TO ANNEX 1
EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market : management & legislation for consumer goods Pharmaceuticals : regulatory framework and market authorisations Brussels, 30 May 2003 Ad
More informationSAFETY DATA SHEET. In accordance with 29 CFR Section 1. Identification of the substance or the mixture and of the supplier
Page ( 6 (/4/206 Section. Identification of the substance or the mixture and of the supplier. Product Identifier Product identifier: Other identifiers:.2 Relevant identified uses of the substance of mixture
More informationAnalysis of Pressure Rise During Internal Arc Faults in Switchgear
Analysis of Pressure Rise During Internal Arc Faults in Switchgear ASANUMA, Gaku ONCHI, Toshiyuki TOYAMA, Kentaro ABSTRACT Switchgear include devices that play an important role in operations such as electric
More informationWARNING! DO NOT THROW AWAY THESE INSTRUCTIONS! READ AND UNDERSTAND BEFORE USING EQUIPMENT!
Guardian Fall Protection Kent, WA 800-466-6385 www.guardianfall.com GENERAL SYSTEM SELECTION CRITERIA: Selection of fall protection shall be made by a Competent Person. All fall protection equipment shall
More information: Pantoprazole Sodium for Injection
SECTION 1: Identification 1.1. Identification Product name Other means of identification : Pantoprazole Sodium for Injection : NDC55150-202-10 (carton of 10 vials); NDC 55150-202-25 (carton of 25 vials)
More informationTopotecan Hydrochloride for Injection
SECTION 1 - IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING Product Name: Topotecan Hydrochloride for Injection Product Use: Pharmaceutical Manufacturer: Intas Pharmaceuticals Ltd.
More informationRespirator Fit Testing DEPARTMENT OF LABOR Information on the Requirements Types of Respirators & Filters
UNITED STATES Respirator Fit Testing DEPARTMENT OF LABOR Information on the Requirements Types of Respirators & Filters This information is about the respirator fit testing requirements for any worker
More informationA study on the relation between safety analysis process and system engineering process of train control system
A study on the relation between safety analysis process and system engineering process of train control system Abstract - In this paper, the relationship between system engineering lifecycle and safety
More informationOperator Exposed to Chlorine Gas
Operator Exposed to Chlorine Gas Lessons Learned Volume 04 Issue 29 2004 USW Operator Exposed to Chlorine Gas Purpose To conduct a small group lessons learned activity to share information gained from
More informationAnnex 8. Guidelines on heating, ventilation and air-conditioning systems for non-sterile pharmaceutical products. Background. Summary of main changes
Annex 8 Guidelines on heating, ventilation and air-conditioning systems for non-sterile pharmaceutical products Background The World Health Organization (WHO) published the first edition of the WHO Guidelines
More informationNZQA unit standard version 3 Page 1 of 8. Manage the mine ventilation system at an extractive site
Page 1 of 8 Title Manage the mine ventilation system at an extractive site Level 7 Credits 30 Purpose This unit standard covers the development and management of the operation and maintenance of a mine
More informationRespiratory Protection Self-Inspection Checklist
Respiratory Protection Self-Inspection Checklist Guidelines: This checklist applies to the use of either atmosphere-supplying or air-purifying respirators being worn, voluntarily or otherwise, for comfort
More informationAnnex 9 Processes Quality Control. Introduction
Annex 9 Processes Quality Control Introduction The eradication of screwworms depends on the release and dispersal into the environment of sterile screwworm flies in optimum biological condition providing
More informationSAFETY DATA SHEET. In accordance with 29 CFR Section 1. Identification of the substance or the mixture and of the supplier
Page ( 6 Issue date: 02/02/207 (02/02/207 In accordance with 29 CFR 90.200 Section. Identification of the substance or the mixture and of the supplier. Product Identifier Product identifier: Other identifiers:.2
More informationLaboratory Standard Operating Procedure: Carcinogens
I. THIS STANDARD OPERATING PROCEDURE (SOP) IS FOR A: Specific laboratory procedure or experiment Examples: synthesis of chemiluminescent esters, folate functionalization of polymeric micelles, etc. Generic
More informationMATERIAL SAFETY DATA SHEET
MATERIAL SAFETY DATA SHEET 1. IDENTIFICATION OF THE SUBSTANCE AND THE COMPANY Material Manufacturer Distributor Ethambutol Hydrochloride Tablets USP 100 mg and 400 mg Lupin Limited Mumbai 400 098 INDIA
More informationSAFETY DATA SHEET Altro Crete primer/top-coat aggregate
SAFETY DATA SHEET SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Product name 1.2. Relevant identified uses of the substance or mixture and uses
More informationIntroduction to Ethylene Oxide (EO/EtO) Sterilization
Introduction to Ethylene Oxide (EO/EtO) Sterilization About Ethylene-Oxide EO is a gas that is 1.5 times heavier than air and tends to settle along the floor. At concentrations below 500 ppm, EO is colorless
More informationWEBINARS. Hazard Communication
WEBINARS Hazard Communication Teaches employees the safe use and handling of hazardous chemicals in the workplace and how to protect themselves and others from those hazards. The modified standard provides
More informationPOLICY FOR THE CONTROL OF SUBSTANCES HAZARDOUS TO HEALTH (COSHH)
POLICY FOR THE CONTROL OF SUBSTANCES HAZARDOUS TO HEALTH (COSHH) INTRODUCTION & LEGISLATION Using chemicals or other hazardous substances at work can put people s health at risk. The law requires employers
More informationCT433 - Machine Safety
Rockwell Automation On The Move May 16-17 2018 Milwaukee, WI CT433 - Machine Safety Performance Level Selection and Design Realization Jon Riemer Solution Architect Safety & Security Functional Safety
More informationANNEX AMENDMENTS TO THE INTERNATIONAL CODE FOR FIRE SAFETY SYSTEMS (FSS CODE) CHAPTER 15 INERT GAS SYSTEMS
Annex 3, page 2 ANNEX AMENDMENTS TO THE INTERNATIONAL CODE FOR FIRE SAFETY SYSTEMS (FSS CODE) CHAPTER 15 INERT GAS SYSTEMS The text of existing chapter 15 is replaced by the following: "1 Application This
More informationSizing of extraction ventilation system and air leakage calculations for SR99 tunnel fire scenarios
Sizing of extraction ventilation system and air leakage calculations for SR99 tunnel fire scenarios Yunlong (Jason) Liu, PhD, PE HNTB Corporation Sean Cassady, FPE HNTB Corporation Abstract Extraction
More informationSafety Data Sheet Safety Data Sheet in accordance with regulation (EC) No 1907/2006, as amended. Date of issue: 31/05/2017 Version: 1.
in accordance with regulation (EC) No 1907/2006, as amended. Date of issue: 31/05/2017 Version: 1.0 SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier
More informationSAFETY DATA SHEET. In accordance with 29 CFR Section 1. Identification of the substance or the mixture and of the supplier
Page 1 ( 7 Issue date: 05/0/018 (05/0/018 Section 1. Identification of the substance or the mixture and of the supplier 1.1 Product Identifier Product identifier: Other identifiers: None 1. Relevant identified
More informationCoking Coal - xxx D Revision no.: 5.00 Page 1 of 6
Page 1 of 6 0. General notes These products are articles according to article 3.3 of regulation (EC) no. 1907/2006 (REACh). It is not necessary to supply a Safety Data Sheet for these products. Safety
More informationVisual Inspection of Medicinal Products for Parenteral Use
Good Practice Paper Visual Inspection of Medicinal Products for Parenteral Use Version 1.0 (September 2014) Version 1.0 1 (16) Acknowledgement This ECA Good Practice Paper was developed by the Steering
More information